Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 18,943 | 0 | 0 | 0 | 0 |
| Gross Profit | 18,943 | 0 | N/A | N/A | N/A |
| Operating Expenses | 17,571 | 29,173 | 11,499 | 14,122 | 5,541 |
| Operating Income | 1,372 | -29,173 | -11,499 | -14,122 | -5,541 |
| Other Income | 47 | 67 | 185 | 247 | 378 |
| Pre-tax Income | 1,419 | -29,106 | -11,314 | -13,875 | -5,163 |
| Net Income Continuous | 1,419 | -29,106 | -11,314 | -13,875 | -5,163 |
| Minority Interests | 1,489 | -760 | -1,456 | -5,253 | -190 |
| Net Income | $-70 | $-28,346 | $-9,858 | $-8,622 | $-4,973 |
| EPS Basic Total Ops | 0.00 | -1.39 | -0.50 | -0.44 | -0.27 |
| EPS Basic Continuous Ops | 0.03 | -1.43 | -0.57 | -0.71 | -0.28 |
| EPS Diluted Total Ops | 0.00 | -1.39 | -0.50 | -0.44 | -0.27 |
| EPS Diluted Continuous Ops | 0.03 | -1.43 | -0.57 | -0.71 | -0.28 |
| EBITDA(a) | $1,387 | $-29,158 | $-11,484 | $-14,106 | $-5,525 |